Similar to our study, Susutlertpanya and colleagues demonstrated that genistein treatment decreased hepatic MDA and TNF-α levels and enhanced PPAR-Υ expression along with the improvement in liver histology in rats with NASH. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.